1. Home
  2. PEO vs EOLS Comparison

PEO vs EOLS Comparison

Compare PEO & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PEO
  • EOLS
  • Stock Information
  • Founded
  • PEO 1929
  • EOLS 2012
  • Country
  • PEO United States
  • EOLS United States
  • Employees
  • PEO N/A
  • EOLS N/A
  • Industry
  • PEO Finance/Investors Services
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • PEO Finance
  • EOLS Health Care
  • Exchange
  • PEO Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • PEO 596.4M
  • EOLS 702.2M
  • IPO Year
  • PEO N/A
  • EOLS 2018
  • Fundamental
  • Price
  • PEO $22.18
  • EOLS $13.00
  • Analyst Decision
  • PEO
  • EOLS Strong Buy
  • Analyst Count
  • PEO 0
  • EOLS 6
  • Target Price
  • PEO N/A
  • EOLS $23.80
  • AVG Volume (30 Days)
  • PEO 35.4K
  • EOLS 920.1K
  • Earning Date
  • PEO 01-01-0001
  • EOLS 03-06-2025
  • Dividend Yield
  • PEO 5.93%
  • EOLS N/A
  • EPS Growth
  • PEO N/A
  • EOLS N/A
  • EPS
  • PEO N/A
  • EOLS N/A
  • Revenue
  • PEO N/A
  • EOLS $248,326,000.00
  • Revenue This Year
  • PEO N/A
  • EOLS $33.43
  • Revenue Next Year
  • PEO N/A
  • EOLS $32.44
  • P/E Ratio
  • PEO N/A
  • EOLS N/A
  • Revenue Growth
  • PEO N/A
  • EOLS 34.42
  • 52 Week Low
  • PEO $19.22
  • EOLS $9.25
  • 52 Week High
  • PEO $23.80
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • PEO 44.79
  • EOLS 52.99
  • Support Level
  • PEO $21.68
  • EOLS $13.83
  • Resistance Level
  • PEO $22.48
  • EOLS $14.92
  • Average True Range (ATR)
  • PEO 0.42
  • EOLS 0.74
  • MACD
  • PEO -0.12
  • EOLS 0.10
  • Stochastic Oscillator
  • PEO 21.62
  • EOLS 63.64

About PEO Adams Natural Resources Fund Inc.

Adams Natural Resources Fund Inc is a closed-end equity investment company specializing in energy and other natural resources stocks. The investment objectives of the fund are the preservation of capital, the attainment of reasonable income from investments, and an opportunity for capital appreciation. Its portfolio of investments comprises of different sector investments such as in the energy sector and basic materials.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: